Assorted News from the Last Week: Over the past year, CAC2 Supporting Organization Member LifeArc has hosted a series of twelve virtual workshops bringing together
Assorted News from the Last Week: ARPA-H announced $50 million to expand pediatric care across the country for patients with complex medical diseases. The program–Pediatric
Assorted News from the Last Week: Two articles of interest about childhood and AYA cancer survivorship: Microvascular skeletal muscle oxygenation linked to exercise capacity in
By CAC2 Staffer Bethany Lieberman In the December 15th, 2025, edition of the CAC2 Community News Digest, two articles stood out. They shed light on the
Assorted News from the Last Week: Accelerated brain aging, atherogenicity, and neurocognition in adult survivors of childhood cancer. The FDA has approved narsoplimab-wuug (Yartemlea) for
Assorted News from the Last Week: Study reveals the profound psychological burden borne not only by childhood cancer survivors but also by their parents, including
Assorted News from the Last Week: CAC2 Board Member Aubrey Reichard-Eline of WITH Grace Initiatives pens powerful Op Ed: “Turning pain into purpose: how service
In CAC2’s December webinar, “Closing the Gaps: Federal Legislation and State Leads for Childhood Cancer Advocacy” we providied an overview of Federal advocacy priorities, current
Assorted News from the Last Week: CAC2 Member Braden’s Hope for Childhood Cancer funds new program to help childhood cancer survivors as they enter adulthood.
Assorted News from the Last Week: American Association for Cancer Research released the AACR Pediatric Cancer Progress Report 2025. Among the trends highlighted: Between 2015 and
